BMSEED was accepted to the NIH I-Corps Program for 2022. The program provides STTR/SBIR awardees with funding, mentoring, and networking opportunities that will aid in commercialization success. BMSEED recently recieved a Phase I SBIR award for the comercialization of the first adaptable, 3D-formfitting pocket microelectrode array for recording from and stimulating organoids. The 8.5-week long I-Corps program will help refine our business plan and opportunities for the technology. Learn more…